 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || BD311 / BDgene
New P1 trial, Gene therapy: VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases (clinicaltrials.gov) - Oct 28, 2021
P1, N=18, Recruiting, Sponsor: Shanghai BDgene Co., Ltd.